New Insights into the Effects of SARS-CoV-2 on Metabolic Organs: A Narrative Review of COVID-19 Induced Diabetes

Coronavirus disease 2019 (COVID-19)-induced new-onset diabetes has raised widespread concerns. Increased glucose concentration and insulin resistance levels were observed in the COVID-19 patients. COVID-19 patients with newly diagnosed diabetes may have worse clinical outcomes and can have serious c...

Full description

Saved in:
Bibliographic Details
Published inDiabetes, metabolic syndrome and obesity Vol. 17; pp. 1383 - 1389
Main Authors Li, Lu, Li, Lin, Cai, Xianhui, Pan, Zongfu
Format Journal Article
LanguageEnglish
Published New Zealand Dove Medical Press Limited 01.01.2024
Dove
Dove Medical Press
Subjects
Adipose tissues
Analysis
Coronaviruses
covid-19
Dextrose
Glucose
Hyperglycemia
Insulin
Insulin resistance
Liver
new-onset diabetes
Pancreatic beta cells
Physiological aspects
Review
sars-cov-2
Severe acute respiratory syndrome
Type 2 diabetes
China
COVID-19
hyperglycemia
SARS-CoV-2
new-onset diabetes
Online AccessGet full text

Cover

More Information
Summary:Coronavirus disease 2019 (COVID-19)-induced new-onset diabetes has raised widespread concerns. Increased glucose concentration and insulin resistance levels were observed in the COVID-19 patients. COVID-19 patients with newly diagnosed diabetes may have worse clinical outcomes and can have serious consequences. The types and exact mechanisms of COVID-19-caused diabetes are not well understood. Understanding the direct effects of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on pancreatic beta cells and insulin target metabolism organs, such as the liver, muscle, and adipose tissues, will provide new ideas for preventing and treating the new-onset diabetes induced by COVID-19.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:1178-7007
1178-7007
DOI:10.2147/DMSO.S454408